Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
04:30:00 21/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 5,764.00 JPY | -1.05% |
|
+3.69% | +19.21% |
| 21/08 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 19/08 | Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading | MT |
| Market Cap | 9,204B 57.89B 49.59B 46.4B 42.48B 79.71B 5,539B 80.77B 548B 214B 2,783B 217B 213B | P/E 2027 * |
46.9x | P/E 2028 * | 29.8x |
|---|---|---|---|---|---|
| Enterprise Value | 13,106B 82.44B 70.62B 66.08B 60.48B 114B 7,888B 115B 781B 304B 3,962B 310B 303B | EV / Sales 2027 * |
2.8x | EV / Sales 2028 * | 2.71x |
| Free-Float |
99.25% | Yield 2027 * |
3.54% | Yield 2028 * | 3.61% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -1.05% | ||
| 1 week | +3.69% | ||
| Current month | +4.55% | ||
| 1 month | +5.18% | ||
| 3 months | +9.69% | ||
| 6 months | -0.45% | ||
| Current year | +19.21% |
| 1 week | 5,504 |  | 5,840 |
| 1 month | 5,225 | | 5,903 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/8/26 | Sell | Head of Human Resources | -12,980 | 0.0008% | ||
| 11/8/26 | Sell | Pres., Global Supply & Quality | -20,363 | 0.0013% | ||
| 10/8/26 | Sell | Pres., Global Supply & Quality | -3,978 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.05% | +3.69% | +26.32% | +31.24% | 58.59B | |
| +1.39% | +6.70% | +77.41% | +128.94% | 1,109B | |
| +1.61% | +4.38% | +51.88% | +62.38% | 644B | |
| +1.63% | +6.58% | +26.91% | +77.07% | 463B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 371B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 301B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 256B | |
| +1.75% | +5.61% | +48.26% | +68.20% | 234B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 205B | |
| +2.34% | +5.87% | +26.12% | +92.89% | 178B | |
| Average | +1.23% | +3.18% | +30.99% | +51.24% | 381.97B | |
| Weighted average by Cap. | +1.41% | +3.28% | +44.42% | +72.38% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,687B 29.48B 25.26B 23.63B 21.63B 40.6B 2,821B 41.13B 279B 109B 1,417B 111B 108B | 4,767B 29.99B 25.69B 24.03B 22B 41.29B 2,869B 41.84B 284B 111B 1,441B 113B 110B |
| Net income | 191B 1.2B 1.03B 964M 882M 1.66B 115B 1.68B 11.39B 4.44B 57.79B 4.51B 4.42B | 316B 1.99B 1.7B 1.59B 1.46B 2.74B 190B 2.77B 18.81B 7.34B 95.5B 7.46B 7.3B |
| Net Debt | 3,902B 24.55B 21.03B 19.67B 18.01B 33.8B 2,349B 34.24B 232B 90.64B 1,180B 92.17B 90.16B | 3,701B 23.28B 19.94B 18.66B 17.08B 32.06B 2,228B 32.48B 220B 85.97B 1,119B 87.42B 85.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | JPY 5,764.00 | -1.05% | 3,177,000 |
| 20/08/26 | JPY 5,825.00 | +0.97% | 5,268,300 |
| 19/08/26 | JPY 5,769.00 | +1.18% | 6,779,900 |
| 18/08/26 | JPY 5,702.00 | +3.43% | 4,655,200 |
| 17/08/26 | JPY 5,513.00 | -1.75% | 2,529,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
